APA (7th ed.) Citation

Richeldi, L., Azuma, A., Cottin, V., Kreuter, M., Maher, T. M., Martinez, F. J., . . . Wijsenbeek, M. S. (2023). Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF). BMJ Open Respiratory Research, 10, . https://doi.org/10.1136/bmjresp-2022-001563

Chicago Style (17th ed.) Citation

Richeldi, Luca, et al. "Design of a Phase III, Double-blind, Randomised, Placebo-controlled Trial of BI 1015550 in Patients with Idiopathic Pulmonary Fibrosis (FIBRONEER-IPF)." BMJ Open Respiratory Research 10 (2023). https://doi.org/10.1136/bmjresp-2022-001563.

MLA (9th ed.) Citation

Richeldi, Luca, et al. "Design of a Phase III, Double-blind, Randomised, Placebo-controlled Trial of BI 1015550 in Patients with Idiopathic Pulmonary Fibrosis (FIBRONEER-IPF)." BMJ Open Respiratory Research, vol. 10, 2023, https://doi.org/10.1136/bmjresp-2022-001563.